| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 12/02/2004 | WO2003085377A3 Novel pancortin-pablo protein interactions and methods of use thereof |
| 12/02/2004 | WO2003084478A3 Antisense modulation of hmgi-c expression |
| 12/02/2004 | WO2003064665A3 Viral vector |
| 12/02/2004 | WO2003063767A3 Rsv proteins, antibodies, compositions, methods and uses |
| 12/02/2004 | WO2003056020A8 Expression vectors and promoters for heterologous gene expression |
| 12/02/2004 | WO2003028632A3 Development of a preventive vaccine for filovirus infection in primates |
| 12/02/2004 | WO2003027240A3 Rhesus monkey, dog and ferret melanin-concentrating hormone type 1 receptor |
| 12/02/2004 | WO2003025119A3 Compositions comprising immunostimulatory oligonucleotides and uses thereof to enhance fc receptor-mediated immunotherapies |
| 12/02/2004 | WO2003022205A3 Methods and compositions for treating vaginal, cervical, and uterine epithelial lesions |
| 12/02/2004 | WO2003006482A3 Use of specific t2r taste receptors to identify compounds that block bitter taste |
| 12/02/2004 | WO2002068583A3 Enzymes having dehalogenase activity and methods of use thereof |
| 12/02/2004 | WO2002051981A3 Defects in periaxin associated with myelinopathies |
| 12/02/2004 | US20040244080 Wheat plants having increased resistance to imidazolinone herbicides |
| 12/02/2004 | US20040244079 Protein that has a function of maintaining a mutation whereby lateral root formation is blocked and a gene encoding the protein |
| 12/02/2004 | US20040244078 Isolated nucleic acid of given sequence, encoding a polypeptide; use in controlling growth and seed development; gene constructs; genetic engineering |
| 12/02/2004 | US20040244077 DWF4 polynucleotides, polypeptides and uses thereof |
| 12/02/2004 | US20040244076 Method for large scale mutagenesis in crop plants |
| 12/02/2004 | US20040244075 Inserting into tissue nucleic acid by inoculation with an Agrobacterium, culturing and regenerating; elevated temperatures; faster and more efficient |
| 12/02/2004 | US20040244074 Selectively recognizing and/or eliminating undesirable soybeans by transforming a plant, collecting the seeds and separating based on size and color; replanting and harvesting resulting in stable transgenic lines |
| 12/02/2004 | US20040244072 Leaf specific gene promoter of coffee |
| 12/02/2004 | US20040244071 Method for stable inversion of dna sequence by site-specific recombination and dna vectors and transgenic cells thereof |
| 12/02/2004 | US20040244070 Expression of polypeptides in rod outer segment membranes |
| 12/02/2004 | US20040244069 Somatic and/or germ cells comprising a nucleic acid with promoter capable of directing protein expression; use in treating, diagnosing and preventing osteoporosis |
| 12/02/2004 | US20040244067 Transgenic mammal which has increased lung mucus retention and whose genome comprises a promoter linked to a heterologous DNA encoding an epithelial sodium channel subunit; useful in treatment of bronchitis and asthma. |
| 12/02/2004 | US20040244065 Cloning vectors and vector components |
| 12/02/2004 | US20040244064 Transgenic flies expressing Abeta42-Flemish |
| 12/02/2004 | US20040244063 Transgenic rodent comprising and expressing nucleotide sequences coding blood coagulation factors for use in treatment of cardiovascular disorders |
| 12/02/2004 | US20040243316 Crystallographic structure of the androgen receptor ligand binding domain |
| 12/02/2004 | US20040242860 Compositions and methods for the diagnosis and treatment of tumor |
| 12/02/2004 | US20040242859 Moraxella (branhamella) catarrhalis polypeptides and corresponding dna fragments |
| 12/02/2004 | US20040242851 Immunoglobulin specifiic for vascular endothelial growth factor receptor for use in treatment and prevention of tumor; angiogenesis inhibitors; antitumor agents; antimetastasis agents; immunotherapy |
| 12/02/2004 | US20040242844 Nucleotide sequences coding streptococcus capsular polysaccharide antigens for use in diagnosis and prevention of infections in mammals; veterinary medicine |
| 12/02/2004 | US20040242601 Use of potent, selective and non toxic c-kit inhibitors for treating interstitial cystitis |
| 12/02/2004 | US20040242529 Vector encoding inactivated telomerase for treating cancer |
| 12/02/2004 | US20040242525 Method for promoting gonadal growth in an animal |
| 12/02/2004 | US20040242523 Combination chemotherapy using a tumor necrosis factor-alpha expression construct and doxorubicin, cyclophosphamide, 5-fluorouracil, taxol or gemcitabine; lower dosages, decreased toxicity |
| 12/02/2004 | US20040242519 Mixing DNA or RNA antiproliferative agents that hybridize with the mRNA that codes for the Ki-67 nuclear protein with a carrier; antitumor, antiarthritic, and antiinflammatory agents, antiallergens, wound healing agents, autoimmune diseases, transplant rejection suppression |
| 12/02/2004 | US20040242518 Influenza therapeutic |
| 12/02/2004 | US20040242517 A nucleic acid construct encoding the antigenic determinant of a mutable pathogen; an isolated cell containing the construct; genetic engineering; vaccination; immunotherapy |
| 12/02/2004 | US20040242516 Antisense modulation of apolipoprotein(a) expression |
| 12/02/2004 | US20040242515 Trp1, mct, or ftz-f1 homologous proteins involved in the regulation of energy home-ostasis |
| 12/02/2004 | US20040242514 Xenogenic oligo or/and polyribonucleotides as agents for the treatment of malignant tumours |
| 12/02/2004 | US20040242512 Novel vectors for animal cells and utilization thereof |
| 12/02/2004 | US20040242487 Identifying a subject in need of inhibiting appetite or weight gain and administering an effective amount of an antagonist of melanocyte concentrating hormone (MCH) to subject, wherein antagonist binds an MCH receptor |
| 12/02/2004 | US20040242484 Specific polypeptides, useful as nematocides |
| 12/02/2004 | US20040242481 Use of hmgb1 for the activation of dendritic cells |
| 12/02/2004 | US20040242476 Peptide and analogs thereof having an amino acid sequence corresponding to the second extracellular domain of a mammalian occludin; may be administered orally or parenterally |
| 12/02/2004 | US20040242462 Detecting that individual's Tob gene, transcript and/or protein and comparing with normal Tob gene, transcript and/or protein, differences present indicating that the probability of that individual suffering from amnesia |
| 12/02/2004 | US20040242461 Modulators of telomere stability |
| 12/02/2004 | US20040242417 Medium for the production of an embryogenic callus from a plant sample and a medium for the regeneration of a plant sample |
| 12/02/2004 | US20040242416 Compositions and methods for intracellular delivery |
| 12/02/2004 | US20040241861 Highly transformable bacterial cells and methods for producing the same |
| 12/02/2004 | US20040241860 Method of breeding glyphosate resistant plants |
| 12/02/2004 | US20040241859 Highly controllable electroporation and applications thereof |
| 12/02/2004 | US20040241857 Tissue specific adenoviral vectors |
| 12/02/2004 | US20040241856 Using hematopoietic stem cell inhibition polypeptide to control differentiation of progenitor cells; for use in tissue engineering, bone marrow transplantation and tumor therapeutics |
| 12/02/2004 | US20040241855 Polyoxyethylene glycol (peg)-lipid-immunogen conjugates; for incorporation into liposomes to enhance intracelllar delivery of nucleic acids and drugs |
| 12/02/2004 | US20040241854 Mammalian cells comprising rna sequences directed towards gene which codes transcript for swedish double amyloid precursor protein mutation or a transcript for tau gene product for use in posttranscriptional gene silencing and treatment of alzheimer's disease; gene therapy |
| 12/02/2004 | US20040241853 Introducing one or more mutations into a template double-stranded polynucleotide via hybridization, replication and amplification of random genomic double stranded and heterozygous oligonucleotides sequences; genomics and directed evolution |
| 12/02/2004 | US20040241852 Functional nucleotide sequence fragments which contain restriction enzyme recognition sites for use as insertional points of heterologous gene sequences |
| 12/02/2004 | US20040241851 Conditional knockout method for gene trapping and gene targeting using an inducible gene silencer |
| 12/02/2004 | US20040241850 Glucosyltransferases which glucosylate abscisic acid |
| 12/02/2004 | US20040241847 Transformed root nodule bacteria comprising genes coding for vibrio catalase for use in transforming plant roots and enhancing nitrogen fixation; pollution control and fertilizers |
| 12/02/2004 | US20040241844 Oligonucleotides for controlling expression of c-reactive protein for use in treatment of infection, autoimmune, diabetic or inflammatory disease |
| 12/02/2004 | US20040241843 Antisense modulation of interleukin 12 p40 subunit expression |
| 12/02/2004 | US20040241838 Reprograming/dedifferentiating somatic cell nucleus via propagation in nutrient broth comprising nuclear factors and soluble components of cytoplasm; tissue engineering and transplantation; generating mammalian pluripotent stem cells from somatic tissue; remodeling somatic nuclei; organ development model |
| 12/02/2004 | US20040241829 Vector for site-specific integration of heterologous dna sequences into metilotrophic yeasts |
| 12/02/2004 | US20040241826 Mycobacterial antigens expressed during latency |
| 12/02/2004 | US20040241824 Identifying nucleotide sequences polymorphisms and/orvariations between methicillin resistant and sensitive bacteria; diagnosis and treatment of infection; using polymorphic sequences to distinguish between bacterial phenotypes; genomics |
| 12/02/2004 | US20040241823 Method and kit for the diagnosis of ulcerative colitis |
| 12/02/2004 | US20040241821 Replication competent yellow fever virus for propagation of immunoglobulin conjugate for use in detection tumor associated antigen expression and treatment of cell proliferative disorders in mammals; cancer diagnosis; immunotherapy |
| 12/02/2004 | US20040241818 Assay |
| 12/02/2004 | US20040241817 Fusion constructs and use of same to produce antibodies with increased Fc receptor binding affinity and effector function |
| 12/02/2004 | US20040241814 Process for the preparation of l-amino acids using strains of the enterobacteriaceae family which contain an enhanced rsea or rsec gene |
| 12/02/2004 | US20040241813 Procsess for the preration of l-amino acids using strains of the enterobacteriaceae family |
| 12/02/2004 | US20040241807 Interleukin-1 related gene and protein |
| 12/02/2004 | US20040241805 Cell surface binding protein for use in treatment, diagnosis and prevention of cancer, inflammation, autoimmunity, allergy, asthma and nervous system disorders |
| 12/02/2004 | US20040241803 25 human secreted proteins |
| 12/02/2004 | US20040241802 Adiponectin receptor and gene encoding the same |
| 12/02/2004 | US20040241801 Production of adenine nucleotide translocator (ANT), novel ANT ligands and screening assays therefor |
| 12/02/2004 | US20040241800 Vascular endothelial growth factor dimers |
| 12/02/2004 | US20040241799 Methods of directing C-O bond formation utilizing a type II polyketide synthase system |
| 12/02/2004 | US20040241797 Use of alphacp1, alphacp2, and hur for modulating gene expression and inducing angiogenesis |
| 12/02/2004 | US20040241796 Kinase for use as tool in identification of modulators for treatment and prevention of diabetic, cell prolliferative, cardiovascular and respiratory system disorders |
| 12/02/2004 | US20040241795 Compounds and methods for inhibiting axillary malodour |
| 12/02/2004 | US20040241793 Isolated human phospholipase proteins, nucleic acid molecules encoding human phospholipase proteins, and uses thereof |
| 12/02/2004 | US20040241792 Substrates and assays for beta-secretase |
| 12/02/2004 | US20040241791 Protein hydrolysates enriched in peptides having a carboxy terminal proline residue |
| 12/02/2004 | US20040241761 Using human estrogen receptor gene expression as diagnostic indicator of diabetes; antidiabetic agents |
| 12/02/2004 | US20040241759 Using encapsulated cells as diagnostic tools for detection of ligand binding proteins and rapid sorting of libraries derived from mixed population of organisms |
| 12/02/2004 | US20040241758 CD 30 ligand |
| 12/02/2004 | US20040241731 Methods of producing nucleic acid ligands |
| 12/02/2004 | US20040241719 Nucleic acid sequence analysis |
| 12/02/2004 | US20040241711 a first specific binding pair (sbp) member capable of binding to the analyte or to a second sbp member to form a complex related to the presence of said analyte, sbp members is bound to a polymer, dispersed in a dopant activating chemiluminescent substance, determining effect of activation |
| 12/02/2004 | US20040241708 Plasmid for use as gene transfer tool in heterologous gene expression; bioreactors |
| 12/02/2004 | US20040241705 Method of determining a chemotherapeutic regimen based on glutathione-s-transferase pi |
| 12/02/2004 | US20040241704 Method for bisulfite treatment |
| 12/02/2004 | US20040241701 Fusing distinct genetic elements to generate preferential proteins; directed protein evolution |
| 12/02/2004 | US20040241698 Extracting actinomycetes nucleotide sequences from soil and identifying biocatalytic nucleotide sequences; for use as tools in genetic engineering |
| 12/02/2004 | US20040241696 Genetic analysis of biological samples in arrayed expanded representations of their nucleic acids |